CORONA
NSECORONA Remedies Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,728.30
45.10 (2.68%)
Medium VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹10.57K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,336.6+29.3%
52W High₹1,949.4-11.3%
Current Price
₹1,728.30
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,382.64
Upper Circuit₹2,073.96
Reference Price
₹1,728.30
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1896.6
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1700.9
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
83%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
1714.19
EMA50
1679.72
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹1785.90
₹1949.40
Support (Below)
₹1724.00
₹1699.00
₹1661.33
₹1638.50
₹1602.80
Volume Analysis
TrendSTABLE
Change-5.60%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹1711.02
3% Risk₹1676.45
5% Risk₹1641.88
7% Risk (Custom)
₹1607.32Technical Levels
1x ATR (Volatility)₹1660.13
2x ATR (Swing)₹1591.96
3x ATR (Trend)₹1523.79
Immediate Support₹1724.00
Moving Averages
EMA 9 (Short-term)₹1719.63
EMA 20 (Medium-term)₹1714.19
EMA 50 (Trend)₹1679.72
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹297.7 Cr | ₹292.8 Cr | ₹346.3 Cr | ₹342.4 Cr |
| Net Profit | ₹45 Cr | ₹31.6 Cr | ₹46.2 Cr | ₹41.3 Cr |
| EPS | ₹7.35 | — | ₹7.55 | ₹6.75 |
| Operating Profit | ₹70.4 Cr | ₹53.3 Cr | ₹71 Cr | ₹66.3 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CORONA
View All
negative
NDTV Profit 28d ago
'Decade Of Crises': PM Modi Flags Corona, War & Energy Crisis; Cautions Of Poverty If Situation Doesn't Improve
PM Modi also personally appealed to overseas Indians to invest back home, calling it "Modi's guarantee."
CORONAENERGYGKENERGYKPELConstructionFinancial Services
positive
CNBC TV18 - Markets 32d ago
Corona Remedies shares fall 3% despite 44% jump in Q4 profit; margins contract
Corona Remedies shares fell over 3% despite strong Q4FY26 and FY26 revenue and profit growth, margin pressure, acquisitions, capacity expansion and EAEU-GMP certification.
CORONAHealthcare
positive
Google News - India Markets 32d ago
Stock Alert: JSW Energy, Heritage Foods, Satin Creditcare, Corona Remedies, Indian Hotels - Business Standard
Stock Alert: JSW Energy, Heritage Foods, Satin Creditcare, Corona Remedies, Indian HotelsBusiness Standard
CORONAENERGYGKENERGYHERITGFOODIEXINDHOTELIREDAJSWENERGYJSWHLJSWINFRAKPELLTFOODSSATINSILConstructionConsumer Services